Multiple sclerosis: Oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules

The expression of major histocompatibility complex (MHC) molecules by oligodendrocytes has been proposed as evidence for their involvement in the multiple sclerosis (MS) lesion although the literature on the subject is controversial and based largely upon observations in vitro. With a modified immun...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroimmunology Vol. 25; no. 2; pp. 261 - 266
Main Authors Lee, Sunhee C., Raine, Cedric S.
Format Journal Article
LanguageEnglish
Published London Elsevier B.V 01.12.1989
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The expression of major histocompatibility complex (MHC) molecules by oligodendrocytes has been proposed as evidence for their involvement in the multiple sclerosis (MS) lesion although the literature on the subject is controversial and based largely upon observations in vitro. With a modified immunocytochemical procedure on 1 μm epoxy sections, the present study has examined the expression of class II MHC molecules (Ia) on cells within actively demyelinating lesions in a central nervous system biopsy from a case of acute MS. White Ia was readily demonstrable on microglial cells aand astrocytes, it was never detected on adjacent surviving oligodendrocytes. Unexpectedly, in parallel sectios, the oligodendrocytes stained positively for myelin-associated glycoprotein, a marker for immature oligodendrocytes. The unequivocal lack of Ia expression by oligodendrocytes in MS makes it unlikely that they serve as immunomodulators in lesion pathogenesis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0165-5728
1872-8421
DOI:10.1016/0165-5728(89)90145-8